Loading clinical trials...
Loading clinical trials...
A Phase 2 Clinical Study to Evaluate The Efficacy and Safety of ALLO-ASC-SHEET in the Subjects With Diabetic Wagner Grade II Foot Ulcers
Conditions
Interventions
ALLO-ASC-SHEET
Locations
1
United States
University of Southern California
Los Angeles, California, United States
Start Date
September 8, 2020
Primary Completion Date
December 1, 2024
Completion Date
June 1, 2025
Last Updated
August 24, 2023
NCT07039396
NCT07396376
NCT07116876
NCT07198061
NCT07014176
NCT07109895
Lead Sponsor
Anterogen Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions